Mannkind (MNKD) Cash from Operations (QoQ) (2010 - 2026)
Mannkind (MNKD) Cash from Operations (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.58% |
| Dec 31, 2025 | -133.66% |
| Sep 30, 2025 | 164.13% |
| Jun 30, 2025 | 240.35% |
| Mar 31, 2025 | -128.16% |
| Dec 31, 2024 | 142.67% |
| Sep 30, 2024 | 143.44% |
| Jun 30, 2024 | -42.82% |
| Mar 31, 2024 | -69.08% |
| Dec 31, 2023 | 150.21% |
| Sep 30, 2023 | 233.74% |
| Jun 30, 2023 | 124.57% |
| Mar 31, 2023 | 148.65% |
| Dec 31, 2022 | 91.54% |
| Sep 30, 2022 | 12.22% |
| Jun 30, 2022 | -75.26% |
| Mar 31, 2022 | -47.79% |
| Dec 31, 2021 | 18.68% |
| Sep 30, 2021 | 29.20% |
| Jun 30, 2021 | -68.46% |